Neutophil-to-platelet volume ratio as a predictor of outcomes for kidney cancer patients
A recent study published in the Archives of Medical Science [...]
Platelet-to-lymphocyte ratio predicts survival outcomes in kidney cancer
In this study, the researchers looked at the association between [...]
Safety and efficacy of apatinib for metastatic kidney cancer
A recent study coming out of China has identified a [...]
Treatment of brain metastases for kidney cancer patients
Brain metastases in patients with renal cell carcinoma (RCC) is [...]
Complete response to immune checkpoint inhibitors in kidney cancer patients
A recent meta-analysis of 6 randomised phase II and III [...]
Biomarkers and outcomes for pembrolizumab/axitinib for kidney cancer
In this phase 1b study, he researchers were looking for [...]
Bacteria in the gut linked to efficacy of immunotherapy
In this study, the investigators looked at the different types [...]
Sarcopenia is prevalent in kidney cancer patients treated with cabozantinib
Sarcopenia is the loss of muscle mass along with reduced [...]
Pembrolizumab plus axitinib combination declined for first-line treatment of advanced kidney cancer
The National Institute for Health and Care Excellence (NICE) have issued [...]
Clinical research cut by 87% at peak of COVID-19 pandemic
Research from University College London published in PLOS One estimated [...]
